A Review of Signet Ring cells in Salivary Gland Tumors
Authors
Abstract:
Objectives: Signet Ring Cells (SRCs) are often seen in gastrointestinal, breast, bile duct and lung invasive carcinomas. Observing these cells in benign and malignant lesions of the salivary glands is not common. Signet-ring cell adenocarcinoma is rare and is commonly seen in the secondary salivary glands. Although, the presence of SRCs in other neoplasms of the body is usually associated with poor prognosis, the prognosis and the survival of malignant tumors of the salivary glands containing SRCs are not well known and few studies have been done. Materials and Methods: In this review article, 18 articles were reviewed from 1984 to 2017 using the pubmed, Google scholar and MEDLINE searches with the keywords Salivary glands, parotid, submandibular, sublingual, and signet ring cells. Results: Viewing SRCs in the salivary glands is not common. Although the Signet Ring Cell Adenocarcinoma has a low incidence, some of them may have been reported as NOS and in fact have a higher incidence. Conclusion: Signet ring cell Adenocarcinoma of the salivary glands is in differential diagnosis with more common tumors of these glands, and further studies are needed to determine the exact prevalence of these salivary tumors that contain SRCs and it seems necessary to predict their biological behavior.
similar resources
D-1 Gene Polymorphism in Salivary Gland Tumors
Objectives This study aimed to assess PD-1gene polymorphism in salivary gland tumors in patients referred to Khalili Hospital in Shiraz. Methods This case-control study evaluated 48 patients with salivary gland tumors and 100 age- and sex-matched healthy controls. First, 5cc blood samples were obtained from patients and transferred to vials containing anti-coagulated EDTA. DNA was extracted, a...
full textMTA1 Expression in Benign and Malignant Salivary gland Tumors
Introduction: Salivary gland tumors (SGTs) are important parts of human neoplasms. The most common SGT is pleomorphic adenoma and the most common malignant SGTs are mucoepidermoid carcinoma and adenoid cystic carcinoma (ACC). Metastasis-associated genes 1 (MTA1), a member of the nucleosome remodeling and histone deacetylation complex, is one newly discovered gene which recruits histone deacetyl...
full textNeoangiogenesis in Benign and Malignant Salivary Gland Tumors
Introduction: There are few studies investigating the role of neoangiogenesis in biological behavior of salivary gland tumors. CD105 expression has demonstrated greater accuracy for detecting new vessel formation compared with other pan-endothelial molecules. This study aimed to assess and compare intratumoral Micro-Vessel Density (MVD) through using immunohistochemichal expression of CD105 bio...
full textMalignant salivary gland tumors
Salivary gland neoplasms are a heterogeneous and important group of tumors of the Oral and Maxillofacial Pathology. They comprise from 2 to 3% of all the salivary gland lesions and tumors1,2 because their heterogeneity, since several years, different classifications based in clinical or microscopic criteria had been appeared.3-7 The most recent and most widely used is that proposed by Seifert e...
full textImmunohistochemical Expression of CD56 and ALDH1 in Common Salivary Gland Tumors
Introduction: Natural killer (NK) cells, of which CD56 is a specific marker, play an important role in host defense against tumors. Cancer stem cells, of which aldehyde dehydrogenase isoform 1 (ALDH1) is an immunohistochemical marker, are a group of tumorigenic cells which are involved in migration and tumor recurrences. We aimed to evaluate the expression of ALDH1 and CD56 in common salivary g...
full textSerum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
Introduction: Cyfra 21 is a serum-soluble fragment of cytokeratin19. Increased Cyfra 21 serum levels and their benefit as a tumor marker have been shown in some malignancies. This study aimed to evaluate the serum levels of Cyfra 21 in patients with benign and malignant salivary gland tumors. Materials and Methods: In this cross-sectional study, the serum level of Cyfra 21 in 44 patients with m...
full textMy Resources
Journal title
volume 7 issue 2
pages 1- 1
publication date 2018-07
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023